Tulathromycin B structure
|
Common Name | Tulathromycin B | ||
---|---|---|---|---|
CAS Number | 280755-12-6 | Molecular Weight | 806.079 | |
Density | 1.2±0.1 g/cm3 | Boiling Point | 870.5±65.0 °C at 760 mmHg | |
Molecular Formula | C41H79N3O12 | Melting Point | N/A | |
MSDS | N/A | Flash Point | 480.3±34.3 °C |
Use of Tulathromycin BTulathromycin B (CP 547272) is an isomer of Tulathromycin (a macrolide antibiotic)[1]. |
Name | Tulathromycin B |
---|---|
Synonym | More Synonyms |
Description | Tulathromycin B (CP 547272) is an isomer of Tulathromycin (a macrolide antibiotic)[1]. |
---|---|
Related Catalog | |
References |
[1]. Ana BERGANT SIMONCIC, et al. Process for preparation of tulathromycin. Patent. WO2015014907. |
Density | 1.2±0.1 g/cm3 |
---|---|
Boiling Point | 870.5±65.0 °C at 760 mmHg |
Molecular Formula | C41H79N3O12 |
Molecular Weight | 806.079 |
Flash Point | 480.3±34.3 °C |
Exact Mass | 805.566345 |
PSA | 200.90000 |
LogP | 3.17 |
Vapour Pressure | 0.0±0.6 mmHg at 25°C |
Index of Refraction | 1.536 |
Storage condition | 2-8°C |
1-Oxa-4-azacyclotridecan-13-one, 11-[[2,6-dideoxy-3-C-methyl-3-O-methyl-4-C-[(propylamino)methyl]-α-L-ribo-hexopyranosyl]oxy]-2-[(1R,2R)-1,2-dihydroxy-1-methylbutyl]-8-hydroxy-3,6,8,10,12-pentamet hyl-9-[[3,4,6-trideoxy-3-(dimethylamino)-β-D-xylo-hexopyranosyl]oxy]-, (2R,3R,6R,8R,9R,10S,11S,12R)- |
(2R,3R,6R,8R,9R,10S,11S,12R)-2-[(2R,3R)-2,3-Dihydroxy-2-pentanyl]-8-hydroxy-3,6,8,10,12-pentamethyl-13-oxo-9-{[3,4,6-trideoxy-3-(dimethylamino)-β-D-xylo-hexopyranosyl]oxy}-1-oxa-4-azacyclotridecan- 11-yl 2,6-dideoxy-3-C-methyl-3-O-methyl-4-C-[(propylamino)methyl]-α-L-ribo-hexopyranoside |
Tulathromycin |
Draxxin |
(2R,3R,6R,8R,9R,10S,11S,12R)-11-[[2,6-Dideoxy-3-C-methyl-3-O-methyl-4-C-[(propylamino)methyl]-a-L-ribo-hexopyranosyl]oxy]-2-[(1R,2R)-1,2-dihydroxy-1-methylbutyl]-8-hydroxy-3,6,8,10,12-pentamethyl-9-[[3,4,6-trideoxy-3-(dimethylamino)-b-D-xylo-hexopyranosyl]oxy]-1-oxa-4-azacyclotridecan-13-one |